Fortrea Holdings (FTRE) Liabilities and Shareholders Equity (2022 - 2026)

Fortrea Holdings (FTRE) reported Liabilities and Shareholders Equity of $2.7 billion for Q1 2026, down 14.02% on a YoY basis from $3.1 billion in Q1 2025, and down 1.19% quarter-over-quarter from $2.7 billion in Q4 2025.

Fortrea Holdings (FTRE) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $2.7 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 14.02% year-over-year to $2.7 billion; the trailing twelve-month figure through Mar 2026 stood at $11.0 billion (down 21.2% YoY), and the FY2025 full-year result was $2.7 billion, down 24.13% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $2.7 billion, down from $2.7 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $4.4 billion in Q2 2023, with the low at $2.7 billion in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $3.6 billion across 5 years, with a median of $3.6 billion in 2024.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity climbed 1.04% — and 2025, when it fell 26.39%.
  • Fortrea Holdings' Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then gained by 1.04% to $4.3 billion in 2023, then declined by 17.39% to $3.6 billion in 2024, then fell by 24.13% to $2.7 billion in 2025, then slipped by 1.19% to $2.7 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $2.7 billion (Q1 2026), $2.7 billion (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 2.68 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.68 Bn
Dec 31, 2025 2.72 Bn
Sep 30, 2025 2.74 Bn
Jun 30, 2025 2.84 Bn
Mar 31, 2025 3.12 Bn
Dec 31, 2024 3.58 Bn
Sep 30, 2024 3.66 Bn
Jun 30, 2024 3.57 Bn
Mar 31, 2024 4.24 Bn
Dec 31, 2023 4.33 Bn
Sep 30, 2023 4.32 Bn
Jun 30, 2023 4.36 Bn
Dec 31, 2022 4.29 Bn